Author

Lucien Vu Dao

Oregon Health & Science University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:scRNA-seq· 1 Organism:yeast· 1

Frequent Co-Authors

Albert Yeam· 1 shared Aline TschanziD· 1 shared Andrew Wong· 1 shared Changhui Xue· 1 shared David G. DrubiniD· 1 shared David Z. QianiD· 1 shared Gean Hu· 1 shared Hao Geng· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

Albert Yeam

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell BiologybioRxivPreprintSep 22, 2026

Phosphoregulation of hierarchical protein condensate formation during clathrin-mediated endocytosis

Yidi Sun, Andrew Wong, Gean Hu…·David G. Drubin

This study identifies two biophysical classes of proteins involved in clathrin-mediated endocytosis and shows how phosphorylation modulates their condensation dynamics.

DOI 10.64898/2026.09.17.752504

yeastexperimental assay

𝕏 PostBluesky

Cancer BiologyThe ProstatePeer-reviewedApr 10, 2025

Understanding the development of enzalutamide resistance based on a functional single-cell approach

Changhui Xue, Hyun‐Kyung Ko, Kasen Shi…·David Z. Qian

This study uses single-cell RNA-sequencing to identify a therapy-resistant subpopulation in prostate cancer cells and discovers a potential therapeutic target for enzalutamide resistance.

3 citations

humanscRNA-seq

𝕏 PostBluesky